CONSERVE Plus Post-Approval Study (PAS)

NCT01367899 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2014-10-28

No results posted yet for this study

Summary

The objective of this post-approval study is to provide scientifically valid and reliable evidence that supports claims of longer term safety and effectiveness with regard to Month 120 device survivorship rates.

Conditions

  • Other and Unspecified Injury to Hip and Thigh

Sponsors & Collaborators

  • MicroPort Orthopedics Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Bolognesi, MD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01367899 on ClinicalTrials.gov